FUT8 (Serbian Wikipedia)

Analysis of information sources in references of the Wikipedia article "FUT8" in Serbian language version.

refsWebsite

Global rank Serbian rank

4^th place

8^th place

2^nd place

4^th place

1,626^th place

low place

6,219^th place

4,555^th place

1semanticscholar.org

11^th place

23^rd place

doi.org (Global: 2^nd place; Serbian: 4^th place)

Costache M, Apoil PA, Cailleau A, Elmgren A, Larson G, Henry S, Blancher A, Iordachescu D, Oriol R, Mollicone R (децембар 1997). „Evolution of fucosyltransferase genes in vertebrates”. J Biol Chem. 272 (47): 29721—8. PMID 9368041. doi:10.1074/jbc.272.47.29721 .
Yu, X; Marshall, MJE; Cragg, MS; Crispin, M (јун 2017). „Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering.” (PDF). BioDrugs. 31 (3): 151—166. PMID 28466278. S2CID 3722081. doi:10.1007/s40259-017-0223-8.

ensembl.org (Global: 1,626^th place; Serbian: low place)

May2017.archive.ensembl.org

GRCm38: Ensembl release 89: ENSMUSG00000021065 - Ensembl, May 2017

nih.gov (Global: 4^th place; Serbian: 8^th place)

ncbi.nlm.nih.gov

„Human PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
„Mouse PubMed Reference:”. National Center for Biotechnology Information, U.S. National Library of Medicine.
Costache M, Apoil PA, Cailleau A, Elmgren A, Larson G, Henry S, Blancher A, Iordachescu D, Oriol R, Mollicone R (децембар 1997). „Evolution of fucosyltransferase genes in vertebrates”. J Biol Chem. 272 (47): 29721—8. PMID 9368041. doi:10.1074/jbc.272.47.29721 .
„Entrez Gene: FUT8 fucosyltransferase 8 (alpha (1,6) fucosyltransferase)”.
Yu, X; Marshall, MJE; Cragg, MS; Crispin, M (јун 2017). „Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering.” (PDF). BioDrugs. 31 (3): 151—166. PMID 28466278. S2CID 3722081. doi:10.1007/s40259-017-0223-8.

semanticscholar.org (Global: 11^th place; Serbian: 23^rd place)

api.semanticscholar.org

Yu, X; Marshall, MJE; Cragg, MS; Crispin, M (јун 2017). „Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering.” (PDF). BioDrugs. 31 (3): 151—166. PMID 28466278. S2CID 3722081. doi:10.1007/s40259-017-0223-8.

soton.ac.uk (Global: 6,219^th place; Serbian: 4,555^th place)

eprints.soton.ac.uk

Yu, X; Marshall, MJE; Cragg, MS; Crispin, M (јун 2017). „Improving Antibody-Based Cancer Therapeutics Through Glycan Engineering.” (PDF). BioDrugs. 31 (3): 151—166. PMID 28466278. S2CID 3722081. doi:10.1007/s40259-017-0223-8.